Tea polyphenols

About us
Green tea extract
civilization of tea
Herb extract
Biochemistry products
Chinese herb
Material base
Equipment
E-shopping
corona-fz@263.net
Chinese
BIG5

 

DOSAGE OF THE CHINESE ANTICANCER HERBAL

PART A PART B PART C
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pingying: Yinhuan She
English: Many -banded krait
Latin: Bungarus m. multicincus m. Blyth

Sources:The dried boby without viscera of Bungarus m. multicincus m. Blyth Family Elapidae.

Constituents: Containing snake venoms, neurotoxins, amino acids phosphodiesterase, arginase, antithromboplastin, etc.

Actions:
Assessed by fluorescent microscopy in vitro, the drug was found to have an antagonistic action on leukemia cells.

Indications:

(1)For primary liver cancer: taking a Bungarus multicinctus B. (weight about 400 1200 gram).A gauze was inserted into the pharyngeal portion of the snake, then to kill it and the fresh bile-cyst was swallowed by the patient. The meat was boiled with quantum sufficit garlic for oral administration. Take out the gauze and head, skin,tail and viscera of snake, and to be baked on voen, then was divided into 4 parts, one part was decocted for oral adminstration every other day. The drug was used for treatment of 4 cases of primary liver cancer. The results showed that 2 cases survived for over 2 years and 1 case survived for over 6 years and 1 case even survived for 14 years, but the lesion was still remained after examination.

(2)Composite prescription for cervical carcinoma :
Syngnathus 1 tiao
Bungarus Paruus 3 tiaos
Hirudo 6g
Tabanus 6g
Unguis Hominis 6g
Rhizoma Coptidis 6g
Olibanum 6g
Myrrba 6g
Scorpio 9g
Nidus Vespae 9g
Cortex Phellodendri 9g
Cortex Moutan 12g
Radix Gentianae 15g

These herbs were powered and mixed with a decoction of Flos Lonicerae to make boluses to be coatedwith Realger. The drug was used to treat 34 cases of cervical carcinoma , 2~3 times daily, 6~9g each time for oral administration. The results showed that 22 cases were effective, the patients survived over 3 years in which stage I cases reached 79%; stage II cases 22.2% and stage III cases 29.4%.

  
 

All Copy: FuZhou Corona Science & Technology Development Co.,Ltd.
Head Office Tel:  86-591-8376-9772 ;  8376-9751    Fax:  86-591-8376-9723
Copyright© 2001-2008 All right reserved